Compare BLTE & VAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLTE | VAL |
|---|---|---|
| Founded | 2018 | 1975 |
| Country | United States | Bermuda |
| Employees | N/A | 5070 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 6.4B |
| IPO Year | 2021 | N/A |
| Metric | BLTE | VAL |
|---|---|---|
| Price | $158.49 | $102.41 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | ★ $198.00 | $64.00 |
| AVG Volume (30 Days) | 117.4K | ★ 868.1K |
| Earning Date | 05-08-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $492.11 | $15.76 |
| P/E Ratio | ★ N/A | $16.22 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $56.68 | $35.20 |
| 52 Week High | $200.00 | $105.35 |
| Indicator | BLTE | VAL |
|---|---|---|
| Relative Strength Index (RSI) | 43.63 | 61.80 |
| Support Level | $157.63 | $86.67 |
| Resistance Level | $161.28 | $103.77 |
| Average True Range (ATR) | 6.26 | 3.62 |
| MACD | -1.15 | 0.96 |
| Stochastic Oscillator | 17.27 | 87.88 |
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.
Valaris Ltd is an offshore contract drilling company. The company provides offshore contract drilling services to the international oil and gas industry with operations in almost every offshore market across six continents. Its business consists of four operating segments: Floaters, which includes drillships and semisubmersible rigs; Jackups; ARO; and Other, which consists of management services on rigs owned by third parties. It generates the majority of its revenue from the Floaters segment.